Duchenne muscular dystrophy Pfizer
Pfizer to abort trials of Duchenne muscular dystrophy drug
Pfizer has decided to abort two of its ongoing clinical trials evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular…
